Autres langues China Isotope & Radiation Corporation

Actions

1763

CNE1000031F4

Equipement, fournitures et distribution médicale

Marché Fermé - Hong Kong S.E. 10:08:08 09/10/2026			Varia. 5j.	Varia. 1 janv.
12,53 ^HKD	-2,79 %		-5,65 %	-37,97 %

23/09	Le dépôt du DMF de l’API Lu-177 de l’unité Isotopes & Radiation de China Isotope franchit l’examen de la FDA américaine	MT
28/08	China Isotope & Radiation Corporation publie ses résultats pour le semestre clos le 30 juin 2026	CI

Autres langues

23/09	China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review
28/08	China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026
28/08	China Isotope & Radiation Corporation Proposes Interim Dividend for the Six Months Ended 30 June 2026, Payable on 18 December 2026
28/08	China Isotope & Radiation Corporation Announces Resignation of Zhang Junqi as an Executive Director, A Member of the Strategy Committee of the Board and A Member of the Science and Technology Innovation Committee of the Board, Effective August 28, 2026
28/08	China Isotope & Radiation Corporation Announces CEO Changes, Effective August 28, 2026
06/07	China Isotope to Form JV With Associate
03/07	China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan
18/06	China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026
18/06	China Isotope & Radiation Corporation Appoints Zhang Guoliang as A Member of Legal Affairs Committee of the Board and A Member of Science and Technology Innovation Committee of the Board
27/05	China Isotope Proposes Auditor Change
26/05	China Isotope & Radiation Corporation Announces Ma Xiaoyu Resignation of Ma Xiaoyu as an Executive Director Member of the Legal Affairs Committee Science and Technology Innovation Committee, Effective May 26, 2026
27/03	China Isotope & Radiation final cash dividend of RMB0.2264 per share
27/03	China Isotope & Radiation Corporation Proposes Final Dividend for the Year Ended December 31, 2025, Payable Before 17 August 2026
27/03	China Isotope & Radiation Corporation Reports Earnings Results for the Full Year Ended December 31, 2025
19/03	China Isotope & Radiation to buy 51% stake in Hunan Huifeng Engineering Detection
13/03	China Isotope & Radiation Corporation, Zhonghe Headway and the People?s Government of Maoming Municipality Enter Strategic Cooperation Agreement
13/03	China Isotope & Radiation says co and Zhonghe Headway enter strategic cooperation agreement with Maoming municipality
02/03	China Isotope & Radiation's Unit Gets China Nod for Market Launch of Breath Analyzer
12/02	China Isotope & Radiation Warns of Up to 25% Lower 2025 Profit
12/02	China Isotope & Radiation Corporation Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025
19/12	China Isotope & Radiation says Zhonghe Headway obtained clinical trial approval for BNCT boron drug
19/12	China Isotope & Radiation's Unit Gets China Nod for Trial of Tumor Drug
15/12	China Isotope & Radiation says unit entered commercial cooperation agreement with Novartis
12/12	China Isotope & Radiation Renews Contracts With CNNC
27/11	China Isotope & Radiation Corp says co, CNNC Capital enter strategic cooperation deal